Mouse models suggest that anti-CSF1R treatment depletes efficiently certain subsets of ResMac but its effect on monocytes showed conflicting results that could be explained by variable dependency on CSF1R across different tumor microenvironment (45, 69, 70). This evidence concerns the gene CSF1R and neoplasm.